PREDiCT: Tumor Models London 2019

December 4 - December 6, 2019
London, UK

Register to Receive News from MI Bioresearch

MI Bioresearch is proud to be a Spotlight Partner of PREDiCT: Tumour Models London 2019. Stop by our booth with any questions or contact us through the form on this page to set up a one-on-one meeting while you are in London. We would be happy to discuss your preclinical oncology and immuno-oncology CRO needs and what MI Bioresearch has to offer in the way of tumour models, oncology pharmacology, in vivo imaging, in vitro services, flow cytometry, and focal radiation.

In attendance:

  • Maryland Franklin, Ph.D. | Vice President, Scientific Development, MI Bioresearch
  • Nikos Afentoulides | Sr. Director, Business Development, MI Bioresearch
  • Bruce Hamilton | Director of Biopharmaceutical Development, Covance

Speaking Engagement:

Thursday, December 5, 2019 | 3:30 p.m.
“Comparative Analysis Between Subcutaneous and Orthotopic Implants of a Murine Pancreatic Carcinoma Model”

  • Understand the rationale for using subcutaneous and orthotopic implants of murine models
  • Comparison of response to checkpoint inhibitor treatments in the two settings
  • Comparison of immune cell infiltration into tumors implanted in both settings

PMaryland Franklin, PhD | Vice President, Scientific Development, MI Bioresearchresented by:
Maryland Franklin, Ph.D.
Vice President, Scientific Development



PREDiCT_Tumor Models London

View the Conference Website